The rating affirmation is based on a number of factors, including URHCS’ growing market position, strong liquidity and designation as a sole community provider.
These strengths are offset by URHCS’ small size and high dependence on governmental payers.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that with its leading market share and operating improvement initiatives, URHCS’s performance and liquidity will remain favorable.
More articles on healthcare finance:
Trinity Health, XPO partner on supply chain management: 5 things to know
Epix Healthcare Associates teams up with investment firm: 4 things to know
St. Francis Medical Center expansion will add 25 new ER beds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit